Table 3.
MIC values (µg/mL) of samples against selected clinical strains of bacteria. Only compounds active at <200 μg/mL in some mycobacterial strains are presented.
| Strain | 1a | 3e | 2f | 3f | 3h | * Gentamicin |
|---|---|---|---|---|---|---|
| E. coli (G−) | >200 | >200 | >200 | 100 | >200 | 0.2 |
| P. aeruginosa (G−) | >200 | >200 | >200 | 100 | >200 | 0.78 |
| S. typhi (G−) | >200 | 100 | >200 | >200 | 100 | 0.1 |
| S. aureus (G+) | 100 | >200 | >200 | 100 | 100 | 0.1 |
| L. innocua (G+) | >200 | >200 | >200 | 100 | >200 | 1.56 |
| L. monocytogenes (G+) | >200 | >200 | >200 | 100 | >200 | 0.2 |
| E. faecalis (G+) | >200 | >200 | >200 | >200 | >200 | 0.78 |
| B. cereus (G+) | >200 | >200 | >200 | 100 | >200 | 0.78 |
| M. luteus (G+) | >200 | >200 | >200 | 100 | >200 | 0.78 |
* Reference drug.